Aarey Drugs & Pharmaceuticals Ltd. reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2015. For the quarter, the company has posted net sales/income from services was INR 322.136 million against INR 488.74 million a year ago. Operating loss before interest was INR 1.534 million against operating profit of INR 4.296 million a year ago. Profit from ordinary activities before tax was INR 4.521 million against INR 2.721 million a year ago. Profit for the period was INR 4.521 million or INR 0.27 basic and diluted per share against INR 2.721 million or INR 0.16 basic and diluted per share a year ago.

For the six months, the company has posted net sales/income from services was INR 740.631 million against INR 834.850 million a year ago. Operating profit before interest was INR 0.621 million against INR 12.504 million a year ago. Profit from ordinary activities before tax was INR 10.530 million against INR 8.505 million a year ago. Profit for the period was INR 10.530 million or INR 0.63 diluted per share against INR 8.505 million or INR 0.51 diluted per share a year ago.